Ion Exchange (India) Ltd gets a Negative outlook on long-term facilities as CRISIL reaffirms A+ rating on ₹2,099.74 crore
- CRISIL also reaffirmed the company’s A1 short-term rating.
- H1FY27 revenue rose 4.5% YoY to ₹1,375 crore; operating margin was -3.8% and PAT was a loss of ₹80 crore.
- CRISIL cited legacy EPC provisions, higher raw-material costs and slower Roha plant ramp-up; it estimates FY27 revenue of about ₹3,000 crore and operating margin of 4–5%.
